The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Hansen Gwenn since 2020.
This trader's CIK number is 1817160.
At the time of last reporting, Hansen Gwenn was the Chief Scientific Officer of Nurix Therapeutics, Inc.. (stock ticker symbol NRIX).
Also see all insider trading activities at Nurix Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | NRIX | 0 | $0 | 11,375 | $164,628 | 29,728 | $0 |
| 2024 | NRIX | 0 | $0 | 11,186 | $196,788 | 28,327 | $0 |
| 2023 | NRIX | 0 | $0 | 6,065 | $54,528 | 16,827 | $0 |
| 2022 | NRIX | 0 | $0 | 5,277 | $99,429 | 11,448 | $15,382 |
| 2021 | NRIX | 0 | $0 | 8,000 | $278,197 | 8,000 | $58,080 |
| 2020 | NRIX | 0 | $0 | 0 | $0 | 12,000 | $10,080 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-07-30 | NRIX | Option Ex | 11,815 | .00 | 0 |
| 2025-07-30 | NRIX | Sale | 4,308 | 12.01 | 51,743 |
| 2025-04-30 | NRIX | Option Ex | 8,956 | .00 | 0 |
| 2025-04-30 | NRIX | Sale | 3,377 | 11.50 | 38,842 |
| 2025-01-30 | NRIX | Sale | 3,690 | 20.07 | 74,043 |
| 2025-01-30 | NRIX | Option Ex | 8,957 | .00 | 0 |
| 2024-10-30 | NRIX | Sale | 3,437 | 24.30 | 83,536 |
| 2024-10-30 | NRIX | Option Ex | 8,957 | .00 | 0 |
| 2024-07-30 | NRIX | Option Ex | 8,957 | .00 | 0 |
| 2024-07-30 | NRIX | Sale | 3,408 | 20.67 | 70,436 |
| 2024-04-30 | NRIX | Sale | 2,007 | 12.04 | 24,168 |
| 2024-04-30 | NRIX | Option Ex | 5,206 | .00 | 0 |
| 2024-01-30 | NRIX | Option Ex | 5,207 | .00 | 0 |
| 2024-01-30 | NRIX | Sale | 2,334 | 7.99 | 18,648 |
| 2023-10-31 | NRIX | Sale | 1,633 | 5.20 | 8,486 |
| 2023-10-30 | NRIX | Option Ex | 5,207 | .00 | 0 |
| 2023-07-30 | NRIX | Option Ex | 5,207 | .00 | 0 |
| 2023-07-31 | NRIX | Sale | 1,884 | 9.65 | 18,190 |
| 2023-04-30 | NRIX | Option Ex | 3,206 | .00 | 0 |
| 2023-05-01 | NRIX | Sale | 1,136 | 9.88 | 11,219 |
| 2023-01-30 | NRIX | Sale | 1,412 | 11.78 | 16,633 |
| 2023-01-30 | NRIX | Option Ex | 3,207 | .00 | 0 |
| 2022-10-31 | NRIX | Sale | 1,165 | 12.88 | 15,006 |
| 2022-10-30 | NRIX | Option Ex | 3,207 | .00 | 0 |
| 2022-07-30 | NRIX | Option Ex | 3,207 | .00 | 0 |
| 2022-08-01 | NRIX | Sale | 1,186 | 15.67 | 18,584 |
| 2022-04-30 | NRIX | Option Ex | 3,206 | .00 | 0 |
| 2022-05-02 | NRIX | Sale | 1,098 | 11.75 | 12,901 |
| 2022-01-03 | NRIX | Option Ex | 1,828 | 8.41 | 15,382 |
| 2022-01-03 | NRIX | Sale | 1,828 | 28.96 | 52,938 |
| 2021-12-01 | NRIX | Option Ex | 400 | 7.26 | 2,904 |
| 2021-12-01 | NRIX | Sale | 400 | 29.13 | 11,652 |
| 2021-11-01 | NRIX | Sale | 400 | 33.24 | 13,296 |
| 2021-11-01 | NRIX | Option Ex | 400 | 7.26 | 2,904 |
| 2021-10-27 | NRIX | Option Ex | 400 | 7.26 | 2,904 |
| 2021-10-27 | NRIX | Sale | 400 | 35.00 | 14,000 |
| 2021-10-01 | NRIX | Sale | 400 | 29.92 | 11,968 |
| 2021-10-01 | NRIX | Option Ex | 400 | 7.26 | 2,904 |
| 2021-09-07 | NRIX | Option Ex | 1,600 | 7.26 | 11,616 |
| 2021-09-07 | NRIX | Sale | 1,600 | 35.00 | 56,000 |
| 2021-09-01 | NRIX | Option Ex | 400 | 7.26 | 2,904 |
| 2021-09-01 | NRIX | Sale | 400 | 32.34 | 12,936 |
| 2021-08-02 | NRIX | Sale | 400 | 31.21 | 12,484 |
| 2021-08-02 | NRIX | Option Ex | 400 | 7.26 | 2,904 |
| 2021-06-01 | NRIX | Option Ex | 400 | 7.26 | 2,904 |
| 2021-06-01 | NRIX | Sale | 400 | 27.74 | 11,096 |
| 2021-05-03 | NRIX | Option Ex | 800 | 7.26 | 5,808 |
| 2021-05-03 | NRIX | Sale | 800 | 34.99 | 27,995 |
| 2021-04-01 | NRIX | Option Ex | 400 | 7.26 | 2,904 |
| 2021-04-01 | NRIX | Sale | 400 | 31.55 | 12,620 |
| 2021-03-16 | NRIX | Sale | 800 | 45.00 | 36,000 |
| 2021-03-16 | NRIX | Option Ex | 800 | 7.26 | 5,808 |
| 2021-03-01 | NRIX | Sale | 800 | 35.95 | 28,760 |
| 2021-03-01 | NRIX | Option Ex | 800 | 7.26 | 5,808 |
| 2021-02-18 | NRIX | Option Ex | 800 | 7.26 | 5,808 |
| 2021-02-18 | NRIX | Sale | 800 | 36.74 | 29,390 |
| 2020-11-30 | NRIX | Option Ex | 12,000 | .84 | 10,080 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Hansen Gwenn (Chief Scientific Officer of Nurix Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.